Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
15.44
+0.17 (1.11%)
At close: Jun 2, 2026, 4:00 PM EDT
15.10
-0.34 (-2.20%)
After-hours: Jun 2, 2026, 7:36 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $156.08 million as of June 2, 2026. Its market cap has increased by 253.56% in one year.
Market Cap
156.08M
Enterprise Value
207.61M
1-Year Change
253.56%
Ranking
Category
Stock Price
$15.44
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $156.08M, a decrease of -53.59%. That is a compound annual growth rate of -12.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 156.08M | 188.50% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 636.02M |
| Fulgent Genetics | 513.77M |
| Myriad Genetics | 404.24M |
| Prenetics Global | 343.13M |
| Insight Molecular Diagnostics | 198.89M |
| Exagen | 129.26M |
| FONAR | 125.20M |
| Burning Rock Biotech | 92.07M |